Danfeng Zhou

Statistics

Publications

Citations

H-Index

Active since

2018

Affiliations

Chinese University of Hong Kong, Shenzhen(Current)

Chongqing Medical University

The Affiliated Yongchuan Hospital of Chongqing Medical University

Chinese University of Hong Kong

Danfeng Zhou is an author at Chinese University of Hong Kong, Shenzhen specializing in tumor suppressor genes, molecular oncology, and cancer cell signaling.

Publications per year

2018–2020

Publications

The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest

Yan Zhang, Jiangxia Fan, Yichao Fan et al. · Clinical Epigenetics · 2018 · 46 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling

Chunfang Tao, Juan Luo, Jun Tang et al. · Clinical Epigenetics · 2020 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–2 of 2